Search Results 8281-8290 of 36493 for oral

1. Combination Treatment Therapy Approaches for the Treatment of High-Risk Multiple Myeloma, REACH Trial - Mayo Clinic

   * Note: subjects intolerant to aspirin may use warfarin, novel oral anticoagulants, or low dose molecular weight heparin. * REGISTRATION-INCLUSION CRITERIA: * ...

2. Surgery - Doctors - Mayo Clinic

   vascular surgery, Parotidectomy, Transoral laser microsurgery, Throat cancer, Oral and throat cancer, Mouth cancer, Thyroid cancer, Head and neck cancer ...

3. Diabetic nephropathy (kidney disease) - Doctors and departments - Mayo Clinic

   Research at Mayo Clinic in diabetic nephropathy includes developing new diagnostic and treatment tools, such as oral medicines that may help stop or delay ...

4. Diabetic nephropathy (kidney disease) - Doctors and departments - Mayo Clinic

   Research at Mayo Clinic in diabetic nephropathy includes developing new diagnostic and treatment tools, such as oral medicines that may help stop or delay ...

5. Spinal cord tumor - Doctors and departments - Mayo Clinic

   ... Oral and throat cancer, Salivary gland cancer, Mouth cancer, Thyroid cancer, Head and neck cancer, Melanoma, Tonsil cancer, Skin cancer, Squamous cell ...

6. The ELiSA Study - Evaluation of Lixivaptan in Subjects With Autosomal Dominant Polycystic Kidney Disease - Mayo Clinic

   ), or oral or intravenous antibiotics within 30 days or 5 half-lives, whichever is longer, prior to Day 1. Subjects will be allowed to take their chronic ...

7. A Study of the Safety and Efficacy of Atezolizumab Administered in Combination With Bevacizumab and/or Other Treatments in Participants With Solid Tumors - Mayo Clinic

   Received oral or IV antibiotics within 2 weeks prior to Cycle 1 Day 1. Significant cardiovascular disease, such as New York Heart Association (NYHA) cardiac ...

8. Julie B. Guerin, M.D. - Doctors and Medical Staff - Mayo Clinic

   Judge for oral and poster sectionsAmerican Society of Pediatric Neuroradiology. 2019 - 2023. Chair, Interesting Case CommitteeAmerican Society of Pediatric ...

9. News Releases - Mayo Clinic News Network

   New CT imaging oral contrast agent improves ...

10. A Phase II Clinical Trial Comparing the Efficacy of RO7198457 Versus Watchful Waiting in Patients With ctDNA-positive, Resected Stage II (High Risk) and Stage III Colorectal Cancer - Mayo Clinic

    ... oral prednisone (or equivalent). * Current or recent (within the 28 days prior to randomization) treatment with another investigational drug. * Toxicities ...